arrow
M

Marion M. Brands

amsterdam gastroenterology endocrinology metabolism
H指数:15
被引数:814

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Screening Tool Improves Recognition of Movement Disorders by Internists and Paediatricians in Patients With Inherited Metabolic Diseases

筛查工具提高了内科医生和儿科医生对遗传代谢病患者运动障碍的识别能力

2025-11-090
OAAI
Potential benefits of l-serine in children with GRIN2B loss-of-function variants: Randomized n-of-1 trials

L-丝氨酸在具有GRIN2B功能丧失性变异的儿童中的潜在益处:随机n-of-1试验

2025-10-300
PRE
A mini-review on the international gyrate atrophy symposium 2023: More than meets the eye. Focus on outstanding research questions

2023国际回旋萎缩研讨会的迷你回顾: 不止是满足眼睛。专注于突出的研究问题

2024-12-010
PRE
Different diseases, different needs: Patient preferences for gene therapy in lysosomal storage disorders, a probabilistic threshold technique survey

不同的疾病,不同的需求: 患者对溶酶体贮积症基因治疗的偏好,概率阈值技术调查

2024-10-032
OAAI
Extending diagnostic practices in gyrate atrophy: Enzymatic characterization and the development of an in vitro pyridoxine responsiveness assay

扩展回旋萎缩的诊断实践: 酶学特性和体外吡哆醇反应性测定的开发

2024-09-012
OAAI
Trial of N-Acetyl-L-Leucine in Niemann-Pick Disease Type C
2024-02-018
PRE
Results of a phase III, randomized, placebo-controlled crossover trial with N-acetyl-L-leucine for Niemann-Pick disease type C
2024-02-010
PRE
Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials
2024-01-044
OAAI
Vision on gyrate atrophy: why treat the eye?
2023-12-144
OAAI
A Delphi Survey Study to Formulate Statements on the Treatability of Inherited Metabolic Disorders to Decide on Eligibility for Newborn Screening

Delphi调查研究,以制定有关遗传性代谢紊乱可治疗性的声明,以决定新生儿筛查的资格

2023-10-114
OAAI